ArticlePancreas2014

Therapeutic administration of orlistat, rosiglitazone, or the chemokine receptor antagonist RS102895 fails to improve the severity of acute pancreatitis in obese mice.

Elise A Malecki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.